• 

• CAS 55837-20-2 Halofuginone

  Description Halofuginone hydrobromide (Halofuginone) is a specific collagen Type I inhibitor that antagonize or inhibit the development of new blood vessels, hence can prevent intimal hyperplasia at a vascular anastomosis. It is used in the treatment or prevention of coccidiosis in both humans and animals.

  
  

  Price on request

  REQUEST NOW

Product Introduction:

Product Name: Halofuginone

Synonyms: 7-Bromo-6-chloro-3[3-(3-hydroxy-2-piperidi-nyl)-2-oxopropyl]-4(3H)-quinzolinone;trans-7-bromo-6-chloro-3-(3-(3-hydroxy-2-piperidinyl)-2-oxopropyl)-4(3h)-qui;trans-l);7-bromo-6-chloro-3-[3-[(2S,3R)-3-hydroxy-2-piperidinyl]-2-oxopropyl]-4-quinazolinone;Halofuginone, >97%;7-bromo-6-chloro-3-[3-[(2r,3s)-3-hydroxy-2-piperidyl]-2-oxopropyl]-4(3h)-quinazolinone;HALOFUGINONE;4(3h)-quinazolinone,7-bromo-6-chloro-3-(3-(3-hydroxy-2-piperidinyl)-2-oxopropy

CAS: 55837-20-2

MF: C16H17BrClN3O3

MW: 414.68

EINECS: 1806241-263-5

Product Categories: Intermediates & Fine Chemicals;Pharmaceuticals

form Solid

pka 14.61±0.40(Predicted)

color White to off-white